| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/13/2004 | EP1466924A1 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV |
| 10/13/2004 | EP1466623A1 Remedies for arthritis |
| 10/13/2004 | EP1466622A1 Medicinal agent and method for curing diseases accompanied with vascular dystonia |
| 10/13/2004 | EP1466616A2 Use of CASB616 polypeptides and polynucleotides for cancer treatment |
| 10/13/2004 | EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid |
| 10/13/2004 | EP1466177A2 Discovery of therapeutic products |
| 10/13/2004 | EP1466175A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465928A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 10/13/2004 | EP1465926A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 10/13/2004 | EP1465925A2 Antibodies that immunospecifically bind to trail receptors |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465920A2 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 10/13/2004 | EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins |
| 10/13/2004 | EP1465896A2 Mitotic kinesin inhibitors |
| 10/13/2004 | EP1465662A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
| 10/13/2004 | EP1465661A1 Cancer treatment |
| 10/13/2004 | EP1465660A2 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 10/13/2004 | EP1465659A2 Use of a novel cell surface protease from group b streptococcus |
| 10/13/2004 | EP1465658A2 Oral vaccination |
| 10/13/2004 | EP1465657A2 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells |
| 10/13/2004 | EP1465656A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 10/13/2004 | EP1465639A2 Adjuvant formulations for bacterial and virus vaccines and method of making same |
| 10/13/2004 | EP1465634A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1257584B1 Humanized antibodies that sequester amyloid beta peptide |
| 10/13/2004 | EP1135166B1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 10/13/2004 | EP1087786B1 Methods and materials for the treatment of prostatic carcinoma |
| 10/13/2004 | EP0873136B1 High fluorescence specific immune enhancing factor and methods of use for same |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | EP0637933B1 Method for treating organs and tissues |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | CN1537167A Von willebrand factor (VWF)-cleaving enzyme |
| 10/13/2004 | CN1537164A Compositions and methods for therapy and diagnosis of Her-2/neu associated malignancies |
| 10/13/2004 | CN1537162A Attenuated circovirus |
| 10/13/2004 | CN1537161A Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 10/13/2004 | CN1537017A Remedie for inflammatory bowel diseases |
| 10/13/2004 | CN1537015A Stable liquid formulations of antibodies |
| 10/13/2004 | CN1537014A HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 10/13/2004 | CN1537013A Nuclec acid adjuvants |
| 10/13/2004 | CN1536083A Low virulent vero strain |
| 10/13/2004 | CN1536077A High-yield recombinant influenza B virus strain and its application |
| 10/13/2004 | CN1535728A Drug composition for curing disease produced from IL-6 |
| 10/13/2004 | CN1535727A Mixed polypeptide vaccine, its preparation and application |
| 10/13/2004 | CN1535726A Molecular adjuvant, its preparation and gene vaccine containing said molecular adjuvant |
| 10/13/2004 | CN1535725A Viral myocarditis gene vaccine, its preparation method and application |
| 10/13/2004 | CN1535681A Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 10/13/2004 | CN1170934C Proteins derived from white spot syndrome virus and uses thereof |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170594C 弯曲菌疫苗 Campylobacter vaccine |
| 10/13/2004 | CN1170593C Immunogenic compsns to CK-b/gastrin-receptor and methods for treatment of tumors |
| 10/12/2004 | US6803449 Polypeptide for use in the diagnosis and treatment viral diseases |
| 10/12/2004 | US6803361 Administering nucleotide sequence |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803189 Methods for the detection of cervical cancer |
| 10/12/2004 | US6803043 Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 10/12/2004 | US6803042 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
| 10/12/2004 | US6803041 Chemically inactivated ehv-1 kya virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer. |
| 10/12/2004 | US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM |
| 10/12/2004 | US6803036 Treating peripheral blood mononuclear cells from donor with transforming growth factor beta, interleukin-2 and at least one other t cell activator; allogenic bone marrow transplants |
| 10/10/2004 | CA2425086A1 Method of increasing the delayed-type hypersensitivity response by infusing lfa-1 specific antibodies |
| 10/07/2004 | WO2004085659A2 Mutant vesicular stomatitis viruses and uses thereof |
| 10/07/2004 | WO2004085658A1 Mutant vesicular stomatitis viruses and use thereof |
| 10/07/2004 | WO2004085648A2 Nogo receptor binding protein |
| 10/07/2004 | WO2004085635A1 Melan-a peptide analogue-virus-like-particle conjugates |
| 10/07/2004 | WO2004085477A1 Treatment of type 1 immune response-mediated inflammatory lung disease by modulation of ifn-gamma activity |
| 10/07/2004 | WO2004085468A2 Human p53 splice variant displaying differential transcriptional activity |
| 10/07/2004 | WO2004085466A2 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | WO2004084941A1 Composition comprising iscom particles and live micro-organisms |
| 10/07/2004 | WO2004084940A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 10/07/2004 | WO2004084939A2 Hiv-peptide-carrier-conjugates |
| 10/07/2004 | WO2004084938A1 Improved vaccines |
| 10/07/2004 | WO2004084937A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 10/07/2004 | WO2004084936A2 Modified free-living microbes, vaccine compositions and methods of use thereof |
| 10/07/2004 | WO2004084935A2 Francisella strain for live vaccine |
| 10/07/2004 | WO2004084927A2 Compositions for inducing of immunotolerance |
| 10/07/2004 | WO2004084839A2 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 10/07/2004 | WO2004084837A2 Methods and compositions for treating and preventing inflammatory conditions |
| 10/07/2004 | WO2004084836A2 Methods for treating taxol-induced gut disorder |
| 10/07/2004 | WO2004084835A2 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 10/07/2004 | WO2004084823A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 10/07/2004 | WO2004084816A2 IMPROVED CD4-IgG2 FORMULATIONS |
| 10/07/2004 | WO2004084805A2 Acetylated tat polypeptides and methods of use thereof |
| 10/07/2004 | WO2004074432A9 Antibody vaccine conjugates and uses therefor |
| 10/07/2004 | WO2004073728A3 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 10/07/2004 | WO2004067698A3 Helminth-derived antigens having capacity of providing protection against parasites |
| 10/07/2004 | WO2004058156A3 High pressure spray-dry of bioactive materials |
| 10/07/2004 | WO2004048402B1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 10/07/2004 | WO2004040262A8 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 10/07/2004 | WO2004038375A3 Water soluble toxin produced by pfiesteria species |
| 10/07/2004 | WO2004029206A3 Targeted cd1d molecules |
| 10/07/2004 | WO2004026427A3 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 10/07/2004 | WO2004024880A3 AMPDs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 10/07/2004 | WO2004021999A3 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 10/07/2004 | WO2004020585B1 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 10/07/2004 | WO2004013279A3 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 10/07/2004 | WO2004010934A3 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 10/07/2004 | WO2003106648A3 Compositions and methods relating to breast specific genes and proteins |